OraSure false positives.

Hm. I found it.

Here's the news story on OraSure's false positives from oral swab tests, which states, in part:

The U.S. Food and Drug Administration approved the OraQuick test for professional use last year. It is now considering a request from drug maker Orasure Technologies, of Bethlehem, Pa., to approve it for home use and over-the-counter sales. What effect the high rate of false positives will have on the decision is not yet known.

This is what I'd call a no-brainer, even though that's not a term I use. I think it's a very bad idea to approve these things for home use. Even the stock price has fallen following the news. If even mere stockbrokers can figure out that it's a bad idea, it's probably a really, *really* bad idea. If I may editorialize briefly, I will.

Now. Why might that be a bad idea? Oh, I don't know, maybe because an unusually high percentage of people (up to around 25% in San Francisco) who use the OraSure oral swab test turn up false positive? Maybe because anyone who'll only test at home is pretty uniquely isolated and vulnerable to begin with? Maybe because anyone testing positive (false or not) absolutely *needs* services available to them *immediately* on hearing their results? Maybe because all the people who test false positive *will* go through a very difficult period of time when they're convinced they're going to die a long, drawn out, and horrible death after years of complex antiretroviral drug therapies while they wince at every cough and sneeze? People have killed themseves for less.

I didn't. Lucky me.

OraSure can, in the words of Crow T. Robot, bite me.